Career Accelerator for Research Infrastructure Scientists

F. Hoffmann-La Roche


At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives and we are fearless in both decision and action. And we believe that good business means a better world.

Roche Pharma Research and Early Development (pRED) translates exceptional science into medical innovation through a diversity of technologies and talent located across seven research sites worldwide. We deliver on individual patient needs through a deep understanding of disease biology and the implementation of Personalized Healthcare strategies.

As a partner in this project, Roche intends to cooperate with the EMBL towards training of the Fellows. Roche can host up to  three Fellows per year in the period 2020-2024 through secondments and introduce them to the ways of working, instrumentation and procedures at Roche Duration of secondments will be between 2 and 6 months and will be arranged in communication with the Fellow. Fellows who will do secondments at Roche will come from the field related or complementary to the field of work of Roche.

At Roche Fellows will have a possibility to learn artificial intelligence and machine learning applied to medical, biological, and chemical questions relevant for the development of medicines. The Fellows will also have a chance to get acquainted with the operation of high performance computing and cloud based services. Roche will dedicate supervision capacity for each fellow on secondments. During secondments, Fellows can stay employed by EMBL.

Roche intends also to host mini-secondments in a duration of up to two weeks, during which Fellows will shadow operations at Roche